Well Told Grants

Federal grant programs / Human Immunodeficiency Virus (HIV)/Acquired Immunodeficiency Virus Syndrome (AIDS) Surveillance

Human Immunodeficiency Virus (HIV)/Acquired Immunodeficiency Virus Syndrome (AIDS) Surveillance in Colorado

Human Immunodeficiency Virus (HIV)/Acquired Immunodeficiency Virus Syndrome (AIDS) Surveillance (93.944) awarded $2.7 million to recipients in Colorado in 2 grants from fiscal 2021 to 2025, 2.2% of the program's national total. Colorado Department of Public Health & Environment received the most, $2.7 million.

By year

Grants under this program to recipients in Colorado
Fiscal yearAwardsAmount
FY 20211$438,646
FY 20221$492,390
FY 20231$733,236
FY 20241$512,352
FY 20251$550,000

Recipients in Colorado

Every recipient named in the data, fiscal 2021 to 2025
RecipientTypeAwardsAmount
Colorado Department of Public Health & EnvironmentState and local governments2$2.7 million

Counted by the recipient's location. A recipient based in Colorado may carry out the work elsewhere.

Open opportunities under this program

None is open or forecast on Grants.gov right now.

Questions people ask

How much Human Immunodeficiency Virus (HIV)/Acquired Immunodeficiency Virus Syndrome (AIDS) Surveillance money goes to Colorado?

$2.7 million from fiscal 2021 to 2025, across 2 awards. Colorado ranks 18th of 23 states and territories for this program.

Who receives Human Immunodeficiency Virus (HIV)/Acquired Immunodeficiency Virus Syndrome (AIDS) Surveillance money in Colorado?

The largest recipient is Colorado Department of Public Health & Environment, with $2.7 million in 2 awards.

Can organizations in Colorado apply now?

No opportunity under this program is open or forecast on Grants.gov right now. Programs often post once a year.

Human Immunodeficiency Virus (HIV)/Acquired Immunodeficiency Virus Syndrome (AIDS) Surveillance in other states

Other large programs in Colorado

All federal grants in Colorado

Amounts are federal obligations reported to USAspending.gov for fiscal 2021 to 2025; see how our data works.